Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Golgi Protein for HCC Diagnosis

View source ↗

Summary

The trial evaluated a Golgi protein as a diagnostic tool for screening hepatocellular carcinoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Screening for Hepatocellular Carcinoma | Status: COMPLETED